BioCentury | Feb 20, 2021
Politics, Policy & Law

Creating access to cancer drugs in Africa

...prices 85-96%, Dent said. The discounts are essential...
BioCentury | Feb 19, 2021
Product Development

First-time CEOs must stop doing what made them successful: Guest Commentary

...of two to three well-balanced assets are essential...
BioCentury | Feb 12, 2021
Product Development

Tau vaccine moving toward late-stage trials for Alzheimer’s

AC Immune believes it has hit on a breakthrough in vaccine technology with its Alzheimer’s candidate ACI-35. The rest of the world will have to wait to evaluate the claim, as the company and partner...
BioCentury | Feb 11, 2021
Deals

Next up: Galapagos, Gilead turn to second IPF program, Toledo molecules after $5B deal’s third setback

A third setback for the $5 billion Galapagos-Gilead deal will now see the partners turn their attention to another fibrosis candidate and a Toledo program that targets salt-inducible kinases. Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) shed nearly $1.3...
BioCentury | Feb 10, 2021
Politics, Policy & Law

Congress considering scrapping Medicaid drug rebate caps

House Democrats are starting what is certain to be a sustained effort to reduce U.S. drug prices by targeting a cap on Medicaid drug rebates that manufacturers must pay when price increases exceed inflation....
BioCentury | Feb 6, 2021
Politics, Policy & Law

Biotech isn’t tech; M&A isn’t all the same

...“A coalition of legislators that value the contribution our industry makes to the nation is essential.”...
...“A coalition of legislators that value the contribution our industry makes to the nation is essential...
BioCentury | Feb 2, 2021
Politics, Policy & Law

Biopharma execs push back on Rep. Porter’s push to rein in M&A

...disagrees with her contention that all biopharma M&A destroys innovation. Acquisitions of small company are essential...
BioCentury | Jan 29, 2021
Politics, Policy & Law

Advocates call for permanent FDA commissioner, line up behind Woodcock, Sharfstein

...is important for public confidence in the agency and to advance policies that will be essential...
BioCentury | Jan 29, 2021
Product Development

Pharma R&D alliance to take on long-term pandemic preparedness

...has removed any doubt that therapeutics remain essential...
BioCentury | Jan 23, 2021
Product Development

Why COVID master protocols haven’t been productive in the U.S., and how to fix it

...healthcare providers the idea that research is essential...
Items per page:
1 - 10 of 2184
BioCentury | Feb 20, 2021
Politics, Policy & Law

Creating access to cancer drugs in Africa

...prices 85-96%, Dent said. The discounts are essential...
BioCentury | Feb 19, 2021
Product Development

First-time CEOs must stop doing what made them successful: Guest Commentary

...of two to three well-balanced assets are essential...
BioCentury | Feb 12, 2021
Product Development

Tau vaccine moving toward late-stage trials for Alzheimer’s

AC Immune believes it has hit on a breakthrough in vaccine technology with its Alzheimer’s candidate ACI-35. The rest of the world will have to wait to evaluate the claim, as the company and partner...
BioCentury | Feb 11, 2021
Deals

Next up: Galapagos, Gilead turn to second IPF program, Toledo molecules after $5B deal’s third setback

A third setback for the $5 billion Galapagos-Gilead deal will now see the partners turn their attention to another fibrosis candidate and a Toledo program that targets salt-inducible kinases. Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) shed nearly $1.3...
BioCentury | Feb 10, 2021
Politics, Policy & Law

Congress considering scrapping Medicaid drug rebate caps

House Democrats are starting what is certain to be a sustained effort to reduce U.S. drug prices by targeting a cap on Medicaid drug rebates that manufacturers must pay when price increases exceed inflation....
BioCentury | Feb 6, 2021
Politics, Policy & Law

Biotech isn’t tech; M&A isn’t all the same

...“A coalition of legislators that value the contribution our industry makes to the nation is essential.”...
...“A coalition of legislators that value the contribution our industry makes to the nation is essential...
BioCentury | Feb 2, 2021
Politics, Policy & Law

Biopharma execs push back on Rep. Porter’s push to rein in M&A

...disagrees with her contention that all biopharma M&A destroys innovation. Acquisitions of small company are essential...
BioCentury | Jan 29, 2021
Politics, Policy & Law

Advocates call for permanent FDA commissioner, line up behind Woodcock, Sharfstein

...is important for public confidence in the agency and to advance policies that will be essential...
BioCentury | Jan 29, 2021
Product Development

Pharma R&D alliance to take on long-term pandemic preparedness

...has removed any doubt that therapeutics remain essential...
BioCentury | Jan 23, 2021
Product Development

Why COVID master protocols haven’t been productive in the U.S., and how to fix it

...healthcare providers the idea that research is essential...
Items per page:
1 - 10 of 2184